Cargando…
APOL1 risk allele RNA contributes to renal toxicity by activating protein kinase R
APOL1 risk alleles associate with chronic kidney disease in African Americans, but the mechanisms remain to be fully understood. We show that APOL1 risk alleles activate protein kinase R (PKR) in cultured cells and transgenic mice. This effect is preserved when a premature stop codon is introduced t...
Autores principales: | , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6220249/ https://www.ncbi.nlm.nih.gov/pubmed/30417125 http://dx.doi.org/10.1038/s42003-018-0188-2 |
_version_ | 1783368786999508992 |
---|---|
author | Okamoto, Koji Rausch, Jason W. Wakashin, Hidefumi Fu, Yulong Chung, Joon-Yong Dummer, Patrick D. Shin, Myung K. Chandra, Preeti Suzuki, Kosuke Shrivastav, Shashi Rosenberg, Avi Z. Hewitt, Stephen M. Ray, Patricio E. Noiri, Eisei Le Grice, Stuart F. J. Hoek, Maarten Han, Zhe Winkler, Cheryl A. Kopp, Jeffrey B. |
author_facet | Okamoto, Koji Rausch, Jason W. Wakashin, Hidefumi Fu, Yulong Chung, Joon-Yong Dummer, Patrick D. Shin, Myung K. Chandra, Preeti Suzuki, Kosuke Shrivastav, Shashi Rosenberg, Avi Z. Hewitt, Stephen M. Ray, Patricio E. Noiri, Eisei Le Grice, Stuart F. J. Hoek, Maarten Han, Zhe Winkler, Cheryl A. Kopp, Jeffrey B. |
author_sort | Okamoto, Koji |
collection | PubMed |
description | APOL1 risk alleles associate with chronic kidney disease in African Americans, but the mechanisms remain to be fully understood. We show that APOL1 risk alleles activate protein kinase R (PKR) in cultured cells and transgenic mice. This effect is preserved when a premature stop codon is introduced to APOL1 risk alleles, suggesting that APOL1 RNA but not protein is required for the effect. Podocyte expression of APOL1 risk allele RNA, but not protein, in transgenic mice induces glomerular injury and proteinuria. Structural analysis of the APOL1 RNA shows that the risk variants possess secondary structure serving as a scaffold for tandem PKR binding and activation. These findings provide a mechanism by which APOL1 variants damage podocytes and suggest novel therapeutic strategies. |
format | Online Article Text |
id | pubmed-6220249 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-62202492018-11-09 APOL1 risk allele RNA contributes to renal toxicity by activating protein kinase R Okamoto, Koji Rausch, Jason W. Wakashin, Hidefumi Fu, Yulong Chung, Joon-Yong Dummer, Patrick D. Shin, Myung K. Chandra, Preeti Suzuki, Kosuke Shrivastav, Shashi Rosenberg, Avi Z. Hewitt, Stephen M. Ray, Patricio E. Noiri, Eisei Le Grice, Stuart F. J. Hoek, Maarten Han, Zhe Winkler, Cheryl A. Kopp, Jeffrey B. Commun Biol Article APOL1 risk alleles associate with chronic kidney disease in African Americans, but the mechanisms remain to be fully understood. We show that APOL1 risk alleles activate protein kinase R (PKR) in cultured cells and transgenic mice. This effect is preserved when a premature stop codon is introduced to APOL1 risk alleles, suggesting that APOL1 RNA but not protein is required for the effect. Podocyte expression of APOL1 risk allele RNA, but not protein, in transgenic mice induces glomerular injury and proteinuria. Structural analysis of the APOL1 RNA shows that the risk variants possess secondary structure serving as a scaffold for tandem PKR binding and activation. These findings provide a mechanism by which APOL1 variants damage podocytes and suggest novel therapeutic strategies. Nature Publishing Group UK 2018-11-07 /pmc/articles/PMC6220249/ /pubmed/30417125 http://dx.doi.org/10.1038/s42003-018-0188-2 Text en © This is a U.S. government work and not under copyright protection in the U.S.; foreign copyright protection may apply 2018 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/. |
spellingShingle | Article Okamoto, Koji Rausch, Jason W. Wakashin, Hidefumi Fu, Yulong Chung, Joon-Yong Dummer, Patrick D. Shin, Myung K. Chandra, Preeti Suzuki, Kosuke Shrivastav, Shashi Rosenberg, Avi Z. Hewitt, Stephen M. Ray, Patricio E. Noiri, Eisei Le Grice, Stuart F. J. Hoek, Maarten Han, Zhe Winkler, Cheryl A. Kopp, Jeffrey B. APOL1 risk allele RNA contributes to renal toxicity by activating protein kinase R |
title | APOL1 risk allele RNA contributes to renal toxicity by activating protein kinase R |
title_full | APOL1 risk allele RNA contributes to renal toxicity by activating protein kinase R |
title_fullStr | APOL1 risk allele RNA contributes to renal toxicity by activating protein kinase R |
title_full_unstemmed | APOL1 risk allele RNA contributes to renal toxicity by activating protein kinase R |
title_short | APOL1 risk allele RNA contributes to renal toxicity by activating protein kinase R |
title_sort | apol1 risk allele rna contributes to renal toxicity by activating protein kinase r |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6220249/ https://www.ncbi.nlm.nih.gov/pubmed/30417125 http://dx.doi.org/10.1038/s42003-018-0188-2 |
work_keys_str_mv | AT okamotokoji apol1riskallelernacontributestorenaltoxicitybyactivatingproteinkinaser AT rauschjasonw apol1riskallelernacontributestorenaltoxicitybyactivatingproteinkinaser AT wakashinhidefumi apol1riskallelernacontributestorenaltoxicitybyactivatingproteinkinaser AT fuyulong apol1riskallelernacontributestorenaltoxicitybyactivatingproteinkinaser AT chungjoonyong apol1riskallelernacontributestorenaltoxicitybyactivatingproteinkinaser AT dummerpatrickd apol1riskallelernacontributestorenaltoxicitybyactivatingproteinkinaser AT shinmyungk apol1riskallelernacontributestorenaltoxicitybyactivatingproteinkinaser AT chandrapreeti apol1riskallelernacontributestorenaltoxicitybyactivatingproteinkinaser AT suzukikosuke apol1riskallelernacontributestorenaltoxicitybyactivatingproteinkinaser AT shrivastavshashi apol1riskallelernacontributestorenaltoxicitybyactivatingproteinkinaser AT rosenbergaviz apol1riskallelernacontributestorenaltoxicitybyactivatingproteinkinaser AT hewittstephenm apol1riskallelernacontributestorenaltoxicitybyactivatingproteinkinaser AT raypatricioe apol1riskallelernacontributestorenaltoxicitybyactivatingproteinkinaser AT noirieisei apol1riskallelernacontributestorenaltoxicitybyactivatingproteinkinaser AT legricestuartfj apol1riskallelernacontributestorenaltoxicitybyactivatingproteinkinaser AT hoekmaarten apol1riskallelernacontributestorenaltoxicitybyactivatingproteinkinaser AT hanzhe apol1riskallelernacontributestorenaltoxicitybyactivatingproteinkinaser AT winklercheryla apol1riskallelernacontributestorenaltoxicitybyactivatingproteinkinaser AT koppjeffreyb apol1riskallelernacontributestorenaltoxicitybyactivatingproteinkinaser |